HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by GARDIN, A. Articles by HUBERT, P. Search for Related Content PubMed PubMed Citation Articles by GARDIN, A. Articles by HUBERT, P.

Substitution of the insulin receptor transmembrane domain with that of glycophorin A inhibits insulin action

INSERM U. 338, 67084 Strasbourg, France; and
^* INSERM U. 36, Collège de France, 3 rue d'Ulm, 75005 Paris, France

¹Correspondence: INSERM U. 338, 5 rue Blaise Pascal, 67084 Strasbourg Cedex, France. E-mail: hubert{at}neurochem.u-strasbg.fr

To study the role of transmembrane (TM) domains interactions in the activation of the insulin receptor, we have replaced the insulin receptor TM domain with that of glycophorin A (GpA), an erythrocyte protein that spontaneously forms detergent-resistant dimers through TM–TM interactions. Insulin receptor cDNA sequences with the TM domain replaced by that of GpA were constructed and stably transfected in CHO cells. Insulin binding to cells and solubilized receptors was not modified. Electrophoresis after partial reduction of disulfide bonds revealed an altered structure for the soluble chimeric receptors, seen as an altered mobility apparently due to increased interactions between the ß subunits of the receptor. Insulin signaling was markedly decreased for cells transfected with chimeric receptors compared with cells transfected with normal receptors. A decrease in insulin-induced receptor kinase activity was observed for solubilized chimeric receptors. In conclusion, substitution by the native GpA TM domain of the insulin receptor results in structurally modified chimeric receptors that are unable to transmit the insulin signal properly. It is hypothesized that this substitution may impose structural constraints that prevent the proper changes in conformation necessary for activation of the receptor kinase. Other mutants modifying the structure or the membrane orientation of the glycophorin A TM domain are required to better understand these constraints.—Gardin, A., Auzan, C., Clauser, E., Malherbe, T., Aunis, D., Crémel, G., Hubert, P. Substitution of the insulin receptor transmembrane domain with that of glycophorin A inhibits insulin action.

Key Words: signaling • tyrosine phosphorylation • receptor dimerization • transfection of chimeric receptors

This article has been cited by other articles:

				A. Bennasroune, M. Fickova, A. Gardin, S. Dirrig-Grosch, D. Aunis, G. Cremel, and P. Hubert Transmembrane Peptides as Inhibitors of ErbB Receptor Signaling Mol. Biol. Cell, July 1, 2004; 15(7): 3464 - 3474. [Abstract] [Full Text] [PDF]

				S. N. Constantinescu, T. Keren, M. Socolovsky, H.-s. Nam, Y. I. Henis, and H. F. Lodish Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain PNAS, April 10, 2001; 98(8): 4379 - 4384. [Abstract] [Full Text] [PDF]